These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37885889)

  • 21. MAIT Cells Balance the Requirements for Immune Tolerance and Anti-Microbial Defense During Pregnancy.
    Raffetseder J; Lindau R; van der Veen S; Berg G; Larsson M; Ernerudh J
    Front Immunol; 2021; 12():718168. PubMed ID: 34497611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and function of circulating mucosal-associated invariant T cells and γδT cells in oral lichen planus.
    Yang JY; Wang F; Zhou G
    J Oral Pathol Med; 2022 Jan; 51(1):74-85. PubMed ID: 34637577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
    Shi L; Lu J; Zhong D; Song M; Liu J; You W; Li WH; Lin L; Shi D; Chen Y
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal-Associated Invariant T Cells in Autoimmune Diseases.
    Chiba A; Murayama G; Miyake S
    Front Immunol; 2018; 9():1333. PubMed ID: 29942318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell profiling reveals kidney CD163
    Chen W; Jin B; Cheng C; Peng H; Zhang X; Tan W; Tang R; Lian X; Diao H; Luo N; Li X; Fan J; Shi J; Yin C; Wang J; Peng S; Yu L; Li J; Wu RQ; Kuang DM; Shi GP; Zhou Y; Wang F; Jiang X
    Ann Rheum Dis; 2024 Apr; 83(5):608-623. PubMed ID: 38290829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-resident mucosal-associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset.
    Terpstra ML; Remmerswaal EBM; van der Bom-Baylon ND; Sinnige MJ; Kers J; van Aalderen MC; Geerlings SE; Bemelman FJ
    Eur J Immunol; 2020 Nov; 50(11):1783-1797. PubMed ID: 32652598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
    Li C; Han Y; Zhang L; Chen Z; Jin M; Sun S
    BMC Nephrol; 2022 Aug; 23(1):296. PubMed ID: 36008770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
    Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
    Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
    Mahajan A; Amelio J; Gairy K; Kaur G; Levy RA; Roth D; Bass D
    Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of memory B- and T-cell subsets in lupus nephritis patients.
    Kosalka J; Jakiela B; Musial J
    Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
    Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus Infection.
    Murugesan A; Ibegbu C; Styles TM; Jones AT; Shanmugasundaram U; Reddy PBJ; Rahman SJ; Saha P; Vijay-Kumar M; Shankar EM; Amara RR; Velu V
    Front Immunol; 2019; 10():3053. PubMed ID: 32010135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: presence, localization, and the effect of immunosuppressive treatment.
    Scheffschick A; Fuchs S; Malmström V; Gunnarsson I; Brauner H
    Clin Exp Immunol; 2022 Apr; 207(2):199-204. PubMed ID: 35020891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
    Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
    Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.